{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T12:33:26Z","timestamp":1782131606427,"version":"3.54.5"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,4,30]],"date-time":"2018-04-30T00:00:00Z","timestamp":1525046400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.cyto.2018.04.014","type":"journal-article","created":{"date-parts":[[2018,5,10]],"date-time":"2018-05-10T00:52:44Z","timestamp":1525913564000},"page":"159-168","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["The localisation of the heparin binding sites of human and murine interleukin-12 within the carboxyterminal domain of the P40 subunit"],"prefix":"10.1016","volume":"110","author":[{"given":"Pascale","family":"Garnier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemary","family":"Mummery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Forster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Mulloy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roslyn V.","family":"Gibbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher C.","family":"Rider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2018.04.014_b0005","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S1074-7613(03)00296-6","article-title":"The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses","volume":"19","author":"Trinchieri","year":"2003","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2018.04.014_b0010","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S1359-6101(03)00043-1","article-title":"The biology of IL-12: coordinating innate and adaptive immune responses","volume":"14","author":"Watford","year":"2003","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.cyto.2018.04.014_b0015","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/ni.2366","article-title":"IL-12 family cytokines: immunological playmakers","volume":"13","author":"Vignali","year":"2012","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cyto.2018.04.014_b0020","doi-asserted-by":"crossref","first-page":"6028","DOI":"10.4049\/jimmunol.1400159","article-title":"Free IL-12p40 monomer is a polyfunctional adaptor for generating novel IL-12-like heterodimers extracellularly","volume":"192","author":"Abdi","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2018.04.014_b0025","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S1074-7613(00)80413-6","article-title":"IL-12-deficient mice are defective in IFN gamma production and type 1 cytokine responses","volume":"5","author":"Magram","year":"1996","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2018.04.014_b0030","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1084\/jem.186.1.39","article-title":"Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis","volume":"186","author":"Cooper","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cyto.2018.04.014_b0035","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1002\/eji.1830260722","article-title":"Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response","volume":"26","author":"Mattner","year":"1996","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cyto.2018.04.014_b0040","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.0105-2896.2005.00227.x","article-title":"Defects in the interferon-gamma and interleukin-12 pathways","volume":"203","author":"Rosenzweig","year":"2005","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.cyto.2018.04.014_b0045","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/MD.0b013e3181fdd832","article-title":"Revisiting human IL-12R\u03b21 deficiency: a survey of 141 patients from 30 countries","volume":"89","author":"de Beaucoudrey","year":"2010","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.cyto.2018.04.014_b0050","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.cytogfr.2014.07.017","article-title":"IL-12-and IL-23 in health and disease","volume":"25","author":"Croxford","year":"2014","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.cyto.2018.04.014_b0055","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/nbt.1903","article-title":"Therapeutic targeting of the IL-12\/23 pathways: generation and characterization of ustekinumab","volume":"29","author":"Benson","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.cyto.2018.04.014_b0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.2012.06670.x","article-title":"Development of the IL-12\/23 antagonist ustekinumab in psoriasis: past, present, and future perspectives\u2013an update","volume":"1263","author":"Yeilding","year":"2012","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.cyto.2018.04.014_b0065","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1136\/annrheumdis-2013-204655","volume":"73","author":"Ritchlin","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cyto.2018.04.014_b0070","doi-asserted-by":"crossref","DOI":"10.1007\/s40265-017-0765-6","article-title":"Ustekinumab: a review in moderate to severe Crohn's disease","author":"Lamb","year":"2017","journal-title":"Drugs"},{"key":"10.1016\/j.cyto.2018.04.014_b0075","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S1359-6101(01)00032-6","article-title":"Interleukin-12 in anti-tumor immunity and immunotherapy","volume":"13","author":"Colombo","year":"2002","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.cyto.2018.04.014_b0080","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.it.2013.07.004","article-title":"A balance of interleukin-12 and -23 in cancer","volume":"34","author":"Ngiow","year":"2013","journal-title":"Trends Immunol."},{"key":"10.1016\/j.cyto.2018.04.014_b0085","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1111\/jcmm.12121","article-title":"Localized interleukin-12 delivery for immunotherapy of solid tumours","volume":"10","author":"Wei","year":"2013","journal-title":"J. Cell Mol. Med."},{"issue":"4","key":"10.1016\/j.cyto.2018.04.014_b0090","doi-asserted-by":"crossref","first-page":"e1285992","DOI":"10.1080\/2162402X.2017.1285992","article-title":"Oncolytic measles virus encoding interleukin-12 mediates potent antitumor effects through T cell activation","volume":"6","author":"Veinalde","year":"2017","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.cyto.2018.04.014_b0095","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0167-5699(92)90140-3","article-title":"Sequence similarity between NKSF and the IL-6\/G-CSF family","volume":"13","author":"Merberg","year":"1992","journal-title":"Immunol. Today"},{"key":"10.1016\/j.cyto.2018.04.014_b0100","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0092-8674(91)90131-H","article-title":"Homology of the p40 subunit of the natural killer cell stimulatory factor (NKSF) with the extracellular domain of the interleukin-6 receptor","volume":"66","author":"Gearing","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.cyto.2018.04.014_b0105","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1093\/emboj\/19.14.3530","article-title":"Charged residues dominate a unique interlocking topography in the heterodimeric cytokine interleukin-12","volume":"19","author":"Yoon","year":"2000","journal-title":"EMBO J."},{"key":"10.1016\/j.cyto.2018.04.014_b0110","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.jmb.2010.07.046","article-title":"Structural basis for the dual recognition of IL-12 and IL-23 by ustekinumab","volume":"402","author":"Luo","year":"2010","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.cyto.2018.04.014_b0115","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.immuni.2017.12.008","article-title":"Structural activation of pro-inflammatory human cytokine IL-23 by cognate IL-23 receptor enables recruitment of the shared receptor IL-12R\u03b21","volume":"48","author":"Bloch","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2018.04.014_b0120","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.4049\/jimmunol.162.2.1064","article-title":"Interleukin 12 is a heparin binding cytokine","volume":"162","author":"Hasan","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2018.04.014_b0125","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1006\/cyto.1997.0246","article-title":"Characterisation of human recombinant interleukin 2 binding to heparin and heparan sulphate using an ELISA approach","volume":"9","author":"Najjam","year":"1997","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2018.04.014_b0130","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1006\/cyto.1996.0142","article-title":"Human interleukin 4 is a glycosaminoglycan-binding protein","volume":"9","author":"Lortat-Jacob","year":"1997","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2018.04.014_b0135","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/jlb.63.3.342","article-title":"Interleukin-5 binds to heparin\/heparan sulfate. A model for an interaction with extracellular matrix","volume":"63","author":"Lipscombe","year":"1998","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.cyto.2018.04.014_b0140","doi-asserted-by":"crossref","first-page":"5671","DOI":"10.4049\/jimmunol.165.10.5671","article-title":"Characterization of the heparin binding properties of interleukin 6","volume":"165","author":"Mummery","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2018.04.014_b0145","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1006\/cyto.1995.0041","article-title":"Interaction of interleukin 7 (IL-7) with glycosaminoglycans and its biological relevance","volume":"7","author":"Clarke","year":"1995","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2018.04.014_b0150","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1146\/annurev-biochem-060713-035314","article-title":"Demystifying heparan sulfate-protein interactions","volume":"83","author":"Xu","year":"2014","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.cyto.2018.04.014_b0155","doi-asserted-by":"crossref","first-page":"16139","DOI":"10.1074\/jbc.271.27.16139","article-title":"Heparin decreases the blood clearance of interferon-gamma and increases its activity by limiting the processing of its carboxyl-terminal sequence","volume":"271","author":"Lortat-Jacob","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cyto.2018.04.014_b0160","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0959-440X(00)00258-X","article-title":"Role of heparan sulphate in fibroblast growth factor signalling: a structural view","volume":"11","author":"Pellegrini","year":"2001","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.cyto.2018.04.014_b0165","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0165-2478(02)00211-0","article-title":"A role for chondroitin sulphate B in the activity of interleukin 12 in stimulating \u03b3-interferon secretion","volume":"85","author":"Garnier","year":"2003","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.cyto.2018.04.014_b0170","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1093\/glycob\/cwg046","article-title":"The binding of human glial cell-line derived neurotrophic factor (GDNF) to heparin and heparan sulphate: importance of 2-O-sulphate groups and effects on its interaction with its receptor GFR\u03b11","volume":"130","author":"Rickard","year":"2003","journal-title":"Glycobiology"},{"key":"10.1016\/j.cyto.2018.04.014_b0175","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nbt0197-35","article-title":"Bioactive murine and human interleukin-12 fusion proteins which retain antitumor activity in vivo","volume":"15","author":"Lieschke","year":"1997","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.cyto.2018.04.014_b0180","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1084\/jem.181.5.1785","article-title":"Ly-49-independent natural killer (NK) cell specificity revealed by NK cell clones derived from p53-deficient mice","volume":"181","author":"Karlhofer","year":"1995","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cyto.2018.04.014_b0185","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1080\/08927020701784754","article-title":"Application of drug discovery software to the identification of heparin-binding sites on protein surfaces: a computational survey of the 4-helix cytokines","volume":"34","author":"Mulloy","year":"2008","journal-title":"Mol. Simul."},{"key":"10.1016\/j.cyto.2018.04.014_b0190","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1042\/bj2930849","article-title":"N.M.R. and molecular\u2013modelling studies of the solution conformation of heparin","volume":"293","author":"Mulloy","year":"1993","journal-title":"Biochem. J."},{"key":"10.1016\/j.cyto.2018.04.014_b0195","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1021\/ci500115j","article-title":"Docking server for the identification of heparin binding sites on proteins","volume":"54","author":"Mottarella","year":"2014","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.cyto.2018.04.014_b0200","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.4049\/jimmunol.146.9.3074","article-title":"Cloning of the cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biological effects on T and natural killer cells","volume":"146","author":"Wolf","year":"1991","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2018.04.014_b0205","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.4049\/jimmunol.147.5.1548","article-title":"IL-12: monoclonal antibodies specific for the p40-kDa subunit block receptor binding and biological activity on activated human lymphoblasts","volume":"147","author":"Chizzonite","year":"1991","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2018.04.014_b0210","doi-asserted-by":"crossref","first-page":"50629","DOI":"10.1074\/jbc.M208956200","article-title":"Mapping the heparin-binding site on the 13\u201314F3 fragment of fibronectin","volume":"277","author":"Sachchidanand","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cyto.2018.04.014_b0215","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/glycob\/9.5.435","article-title":"Recombinant human interleukin-12 is the second example of a C-mannosylated protein","volume":"9","author":"Doucey","year":"1999","journal-title":"Glycobiology"},{"key":"10.1016\/j.cyto.2018.04.014_b0220","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms6237","article-title":"Structural basis of IL-23 antagonism byan Alphabody protein scaffold","volume":"5","author":"Desmet","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cyto.2018.04.014_b0225","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.pep.2014.07.002","article-title":"Efficient production and purification of recombinant human interleukin-12 (IL-12) overexpressed in mammalian cells without affinity tag","volume":"102","author":"Jayanthi","year":"2014","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.cyto.2018.04.014_b0230","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1093\/glycob\/cwm082","article-title":"The binding of human betacellulin to heparin, heparan sulfate and related polysaccharides","volume":"17","author":"Mummery","year":"2007","journal-title":"Glycobiology"},{"key":"10.1016\/j.cyto.2018.04.014_b0235","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1042\/BJ20150228","article-title":"Mapping the heparin binding site of the BMP antagonist gremlin by site-directed mutagenesis based on predictive modelling","volume":"470","author":"Tatsinkam","year":"2015","journal-title":"Biochem. J."},{"key":"10.1016\/j.cyto.2018.04.014_b0240","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.cytogfr.2014.04.007","article-title":"Who climbs the tryptophan ladder? On the structure and function of the WSXWS motif in cytokine receptors and thrombospondin repeats","volume":"25","author":"Olsen","year":"2014","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.cyto.2018.04.014_b0245","doi-asserted-by":"crossref","first-page":"5360","DOI":"10.1038\/s41598-017-05382-1","article-title":"Modulation of interleukin-12 activity in the presence of heparin","volume":"7","author":"Jayanthi","year":"2017","journal-title":"Sci Rep."},{"key":"10.1016\/j.cyto.2018.04.014_b0250","doi-asserted-by":"crossref","first-page":"4133","DOI":"10.1182\/blood-2011-12-400044","article-title":"Tumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning","volume":"119","author":"Pegram","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2018.04.014_b0255","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0014-5793(01)02603-5","article-title":"Sequence analyses and comparative modelling of fly and worm fibroblast growth factor receptors indicate that the determinants for FGF and heparin binding are retained in evolution","volume":"501","author":"Nagendra","year":"2001","journal-title":"FEBS Lett."},{"key":"10.1016\/j.cyto.2018.04.014_b0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20100305","article-title":"Bone morphogenetic protein and growth differentiation factor cytokine families and their protein antagonists","volume":"429","author":"Rider","year":"2010","journal-title":"Biochem. J."},{"key":"10.1016\/j.cyto.2018.04.014_b0265","doi-asserted-by":"crossref","first-page":"6113","DOI":"10.1021\/bi200291e","article-title":"The metastasis-associated extracellular protein osteopontin forms transient structure in ligand interactive sites","volume":"50","author":"Platzer","year":"2011","journal-title":"Biochemistry"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466618301674?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466618301674?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:52:02Z","timestamp":1760907122000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466618301674"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":53,"alternative-id":["S1043466618301674"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2018.04.014","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The localisation of the heparin binding sites of human and murine interleukin-12 within the carboxyterminal domain of the P40 subunit","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2018.04.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}